Effect of beta-blocker dose on mortality after acute coronary syndrome

1985, Metoprolol in Acute Myocardial Infarction (MIAMI). A randomised placebo-controlled international trial, Eur Heart J, 6, 199, 10.1093/oxfordjournals.eurheartj.a061845 Hjalmarson, 1981, Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomised trial, Lancet, 2, 823, 10.1016/S0140-6736(81)91101-6 2001, Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial, Lancet, 357, 1385, 10.1016/S0140-6736(00)04560-8 Choo, 2014, Benefit of β-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary intervention, Heart, 100, 492, 10.1136/heartjnl-2013-305137 Lee, 2015, β-Blocker therapy in the era of primary percutaneous intervention for ST elevation myocardial infarction, Cardiology, 132, 91, 10.1159/000431077 Raposeiras-Roubín, 2015, Prognostic benefit of beta-blockers after acute coronary syndrome with preserved systolic function. Still relevant today?, Rev Esp Cardiol (Engl Ed), 68, 585, 10.1016/j.recesp.2014.07.029 Steg, 2012, ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur Heart J, 33, 2569, 10.1093/eurheartj/ehs215 O’Gara, 2013, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 61, e78, 10.1016/j.jacc.2012.11.019 Roffi, 2016, Eur Heart J, 37, 267, 10.1093/eurheartj/ehv320 Amsterdam, 2014, 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 64, e139, 10.1016/j.jacc.2014.09.017 Gottlieb, 1998, Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction, N Engl J Med, 339, 489, 10.1056/NEJM199808203390801 Barron, 1998, Beta-blocker dosages and mortality after myocardial infarction: data from a large health maintenance organization, Arch Intern Med, 158, 449, 10.1001/archinte.158.5.449 1999, The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomised trial, Lancet, 353, 9, 10.1016/S0140-6736(98)11181-9 Goldberger, 2015, Effect of beta-blocker dose on survival after acute myocardial infarction, J Am Coll Cardiol, 66, 1431, 10.1016/j.jacc.2015.07.047 Allen, 2017, β-blocker dosage and outcomes after acute coronary syndrome, Am Heart J, 184, 26, 10.1016/j.ahj.2016.10.012 Goldberger, 2010, beta-Blocker use following myocardial infarction: low prevalence of evidence-based dosing, Am Heart J, 160, 435, 10.1016/j.ahj.2010.06.023 Krumholz, 1998, National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project, JAMA, 280, 623, 10.1001/jama.280.7.623 Ko, 2002, Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction, JAMA, 288, 351, 10.1001/jama.288.3.351 Freemantle, 1999, beta-Blockade after myocardial infarction: systematic review and meta regression analysis, BMJ, 318, 1730, 10.1136/bmj.318.7200.1730 Bloch Thomsen, 2010, Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study, Circulation, 122, 1258, 10.1161/CIRCULATIONAHA.109.902148 Muthumala, 2008, Role of beta adrenergic receptor polymorphisms in heart failure: systematic review and meta-analysis, Eur J Heart Fail, 10, 3, 10.1016/j.ejheart.2007.11.008 Cucherat, 2007, Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials, Eur Heart J, 28, 3012, 10.1093/eurheartj/ehm489 Kjekshus, 1986, Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials, Am J Cardiol, 57, 10.1016/0002-9149(86)90888-X